SCHEMBL7849396

SCHEMBL7849396

CN(CC(=O)O)S(=O)(=O)c1[c]cccc1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KDM4E B2RXH2 2/20 0.43
POLB P06746 2/20 0.39
HPGD P15428 1/20 0.39
KEAP1 Q14145 4/20 0.39
NFE2L2 Q16236 3/20 0.39
MAPK1 P28482 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6752176 0.83 KEAP1 (0.43) ALDH1A1KEAP1NFE2L2MAPK1
SCHEMBL7851053 0.81 ALDH1A1 (0.39) ALDH1A1L3MBTL1KDM4EHPGDKMT2A
SCHEMBL2334379 0.78 KEAP1 (0.56) ALDH1A1L3MBTL1KDM4EPOLBKEAP1
SCHEMBL6752244 0.77 HTR2A (0.36) KDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL6750723 0.76 TAAR1 (0.46) ALDH1A1MAPK1
SCHEMBL182586 0.75 ALDH1A1 (0.40) ALDH1A1KDM4EPOLBHPGDKMT2A
SCHEMBL6745866 0.74 HDAC4 (0.36) ALDH1A1KMT2A
SCHEMBL7849449 0.73 SMN1; SMN2 (0.51) ALDH1A1POLBKEAP1NFE2L2SMN1; SMN2
SCHEMBL7410161 0.73 CA12 (0.51) ALDH1A1L3MBTL1KDM4EMAPK1KMT2A
SCHEMBL15705773 0.72 MMP1 (0.54) ALDH1A1KDM4EKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115704-A1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES Boehringer Ingelheim Pharma KG (DE) 2001-07-18 EP disclosed
WO-2000018734-A1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-04-06 WO disclosed